Kidney Cancer Linked to Kidney Stones
Meta-analysis reveals a significantly increased risk of kidney stones only in male patients with kidney cancer.
Meta-analysis reveals a significantly increased risk of kidney stones only in male patients with kidney cancer.
Use of these agents is associated with a much lower incidence of hypercalcemia compared with the use of calcium carbonate or calcium acetate.
Calciphylaxis was 75% less likely to develop in patients who received the drug rather than placebo.
Researchers in the Netherlands report results from an autopsy study of diabetic nephropathy patients.
Over 52 weeks, the drug maintained hemoglobin levels while decreasing IV iron use in dialysis patients with anemia.
In adjusted analyses, serum phosphorus levels independently predicted glucose disposal rate.
Benefit seen among anemia and hemodialysis patients with hemoglobin levels below 10 g/dL.
Each 0.5 mg/dL increment in serum phosphorus associated with 58% increased odds of coronary heart failure (CHF).
Aspirin and clonidine increased the risk of major bleeding and clinically important hypotension in acute kidney injury (AKI).
Renal events are significantly less likely if erythropoiesis-stimulating agents are started at hemoglobin levels below 11 g/dL.